Bioreactor technologies to support liver function in vitro
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Liver is a central nexus integrating metabolic and immunologic homeostasis in the human body, and the direct or indirect target of most molecular therapeutics. A wide spectrum of therapeutic and technological needs drive efforts to capture liver physiology and pathophysiology in vitro, ranging from prediction of metabolism and toxicity of small molecule drugs, to understanding off-target effects of proteins, nucleic acid therapies, and targeted therapeutics, to serving as disease models for drug development. Here we provide perspective on the evolving landscape of bioreactor-based models to meet old and new challenges in drug discovery and development, emphasizing design challenges in maintaining long-term liver-specific function and how emerging technologies in biomaterials and microdevices are providing new experimental models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lutolf, M. P., & Hubbell, J. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1055 · Cited by 4,551
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Quiescent hepatic stellate cells comprise 5–8% of total liver cells, are present within the space of Disse at a ratio of approximately 1 stellate cell for 6 hepatocytes, store 80% of body vitamin A, and participate in hepatic wound healing, regulation of sinusoidal blood flow, angiogenesis and hepatocyte growth [13].”
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Endotoxin tolerance: new mechanisms, molecules and clinical significance
Biswas, S. K., & Lopez-Collazo, E. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.009 · Cited by 1,318
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · cited 2×
“Excellent perspective on how these types of microfluidic systems for slice culture and other forms of culture, including limitations of the PDMS materials and possible mitigations of these limitations [64], is provided in recent reviews by Groothuis and co-workers [1,3,143].”
Crispe, I. N. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132629 · Cited by 986
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722
Biological implications of polydimethylsiloxane-based microfluidic cell culture
Regehr, K. J., Domenech, M., Koepsel, J. T., Carver, K. C., Ellison-Zelski, S. J., Murphy, W. L., Schuler, L. A., Alarid, E. T., & Beebe, D. J. (2009) · Lab on a Chip · doi:10.1039/b903043c · Cited by 719
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
Inconsistency in large pharmacogenomic studies
Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C., Beck, A. H., Aerts, H. J. W. L., & Quackenbush, J. (2013) · Nature · doi:10.1038/nature12831 · Cited by 499 · cited 1×
“This application may be driven faster by the needs of personalized medicine, as the limitations of genomic studies to predict how patients will respond to therapies are becoming more apparent [209], motivating experimental approaches that integrate complexity.”
Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50234a · Cited by 476 · cited 1×
“Marx and coworkers described interactions between interconnected transwell-type cultures of skin biopsies and spheroids generated from the cell line HepaRG cells combined with a stellate cell line, with the interesting observation that the skin biopsies appeared to consume albumin produced by the hepatocytes, consiste…”
Lumsden, A. B., Henderson, M. J., & Kutner, M. H. (1988) · Hepatology · doi:10.1002/hep.1840080207 · Cited by 427 · cited 2×
“0 ng/mL in portal venous blood [9]) where they provide constant stimulation to the extensive immune system in the liver [10] and influence immune tolerance in both the liver and the entire body [11].”
Cell Culture on Artificial Capillaries: an Approach to Tissue Growth In Vitro
Knazek, R. A., Gullino, P. M., Kohler, P. O., & Dedrick, R. L. (1972) · Science · doi:10.1126/science.178.4056.65 · Cited by 424 · cited 1×
“Hollow fiber cell culture reactors emerged over 30 years ago as a means to culture mammalian cells on a large scale for biotechnology applications, such as protein and vaccine production, complementing approaches based on stirred-tank reactors and roller bottle cultures [99].”
A novel 3D mammalian cell perfusion-culture system in microfluidic channels
Toh, Y.-C., Zhang, C., Zhang, J., Khong, Y. M., Chang, S., Samper, V. D., van Noort, D., Hutmacher, D. W., & Yu, H. (2007) · Lab on a Chip · doi:10.1039/b614872g · Cited by 414 · cited 1×
“In the original description of the device, following seeding of primary rat hepatocytes, the culture was not strictly matrix-free, as support for the cells was added by post-seeding coacervation of a collagen-synthetic polyelectrolyte to stabilize the 3D arrangement of cells, and this arrangement led to viability over…”
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b915147h · Cited by 340 · cited 1×
“A complex 4-way interaction involving compartmentalized culture of liver, lung, kidney, and fat cell lines in an interconnected microfluidic device similar to one described above [155] was described by the Yu group [154].”
Mechanisms of tumor cell extravasation in an in vitro microvascular network platform
Chen, M. B., Whisler, J. A., Jeon, J. S., & Kamm, R. D. (2013) · Integrative Biology · doi:10.1039/c3ib40149a · Cited by 308 · cited 2×
“This system has recently been applied to analysis of extravasation of tumor cells from microvascular networks [168], and accordingly may find application in more complex liver angiogenesis applications in the future.”
Geometric control of vascular networks to enhance engineered tissue integration and function
Baranski, J. D., Chaturvedi, R. R., Stevens, K. R., Eyckmans, J., Carvalho, B., Solorzano, R. D., Yang, M. T., Miller, J. S., Bhatia, S. N., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217796110 · Cited by 267
Yamada, M., Utoh, R., Ohashi, K., Tatsumi, K., Yamato, M., Okano, T., & Seki, M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.068 · Cited by 247
Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor
Powers, M. J., Janigian, D. M., Wack, K. E., Baker, C. S., Stolz, D. B., & Griffith, L. G. (2002) · Tissue Engineering · doi:10.1089/107632702760184745 · Cited by 234 · cited 2×
“microperfusion as evidenced by 2-photon observance of expression of EGFP following adenoviral gene delivery [139][138].”
Self-citationvan Midwoud, P. M., Merema, M. T., Verpoorte, E., & Groothuis, G. M. M. (2010) · Lab on a Chip · doi:10.1039/c0lc00043d · Cited by 203
A gel-free 3D microfluidic cell culture system
Ong, S.-M., Zhang, C., Toh, Y.-C., Kim, S. H., Foo, H. L., Tan, C. H., van Noort, D., Park, S., & Yu, H. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.022 · Cited by 172 · cited 3×
“Another approach to creating a gel-free microfluidic tissue culture PDMS microdevice has been developed over several iterations by Yu and co-workers (Figure 12a,b)[48,151–154] [155][156].”
In vitro analysis of a hepatic device with intrinsic microvascular-based channels
Carraro, A., Hsu, W.-M., Kulig, K. M., Cheung, W. S., Miller, M. L., Weinberg, E. J., Swart, E. F., Kaazempur-Mofrad, M., Borenstein, J. T., Vacanti, J. P., et al. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9194-3 · Cited by 168
Microfluidic devices for in vitro studies on liver drug metabolism and toxicity
van Midwoud, P. M., Verpoorte, E., & Groothuis, G. M. M. (2011) · Integrative Biology · doi:10.1039/c0ib00119h · Cited by 115
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., & Wamhoff, B. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2012 · Cited by 108
Cross-presentation of antigen by diverse subsets of murine liver cells
Ebrahimkhani, M. R., Mohar, I., & Crispe, I. N. (2011) · Hepatology · doi:10.1002/hep.24508 · Cited by 102
Self-citationStimson, R. H., Mohd-Shukri, N. A., Bolton, J. L., Andrew, R., Reynolds, R. M., & Walker, B. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2307 · Cited by 74
Endotoxin Stimulates Hepatocyte Interleukin-6 Production
Panesar, N., Tolman, K., & Mazuski, J. E. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5648 · Cited by 56 · cited 1×
“Adding further to the complexity of the immunological networks in liver, hepatic parenchymal cells exhibit some immunological properties such as expression of Toll-like receptors (TLRs) and secretion of IL-6 and other cytokines [23,24].”
Poyck, P. P. C., Hoekstra, R., van Wijk, A. C. W. A., Attanasio, C., Calise, F., Chamuleau, R. A. F. M., & van Gulik, T. M. (2007) · Liver Transplantation · doi:10.1002/lt.21090 · Cited by 49 · cited 1×
“An alternate hollow fiber design combined fiber matrix sheets interspersed with hollow fibers to similarly address the high oxygen demands of hepatocytes by providing a set of hollow fibers for gas exchange in the context of adhesion to the fibers was developed by Chamuleau and coworkers for clinical application and h…”
Cited by
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612906114 · Cited by 833
A decade of progress in tissue engineering
Khademhosseini, A., & Langer, R. (2016) · Nature Protocols · doi:10.1038/nprot.2016.123 · Cited by 747
Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling
Chaicharoenaudomrung, N., Kunhorm, P., & Noisa, P. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i12.1065 · Cited by 360
Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
Liu, Q., Zhang, H., Jiang, X., Qian, C., Liu, Z., & Luo, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0742-4 · Cited by 332
In silico clinical trials: how computer simulation will transform the biomedical industry
Viceconti, M., Henney, A., & Morley-Fletcher, E. (2016) · International Journal of Clinical Trials · doi:10.18203/2349-3259.ijct20161408 · Cited by 289
Metadata
- Authors
- Ebrahimkhani, M. R., Neiman, J. A. S., Raredon, M. S. B., Hughes, D. J., & Griffith, L. G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 69-70
- Pages
- 132-157
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2273947099
- Cited by
- 135
- References
- 32
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.